Skip to content

Clinical trials

Adenocarcinoma, Bronchiolo-Alveolar trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma, Bronchiolo-Alveolar Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20015
20028
20031
20049
200514
200614
20077
20086
20096
20103
20114
20131
20143
20161
20172
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Terminated17
Unknown status8
Active, not recruiting5
Withdrawn3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)17
Alliance for Clinical Trials in Oncology13
Radiation Therapy Oncology Group5
Wake Forest University Health Sciences5
ECOG-ACRIN Cancer Research Group4
Eastern Cooperative Oncology Group4
SWOG Cancer Research Network4
Barbara Ann Karmanos Cancer Institute3
Memorial Sloan Kettering Cancer Center3
University of Texas Southwestern Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma, Bronchiolo-Alveolar103
Carcinoma, Non-Small-Cell Lung93
Adenocarcinoma of Lung85
Lung Neoplasms79
Neoplasm Metastasis5
Small Cell Lung Carcinoma4
Adenocarcinoma3
Adenocarcinoma in Situ2
Bile Duct Neoplasms2
Brain Neoplasms2

Trials

Showing 51 to 75 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.